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ABSTRACT 
 
The routine identification of mycobacterial strains isolated from patients in different locations in Egypt was confirmed by 
specific  DNA  fragment  amplification.  The  susceptibilities  of  72  Mycobacterium  tuberculosis  strains  against  the  four 
antibiotics used in tuberculosis treatment (Isoniazid, INH; Rifampicin, Rif; Streptomycin, St and Ethambutol, E) were 
examined. Our results indicated that, multi drug resistant tuberculosis (MDR-TB) represents about 19.5% of the tested 
strains, whereas sensitive strains represented 26.4%. The genetic polymorphism of the tested strains was examined 
using RAPD analysis. Six selected strains represent the different antibiotic susceptibility groups were examined using 
RAPD fingerprinting. No difference between  the strains was recorded using the RFLP analysis of amplified specific 
fragment. The discrimination power of RAPD analysis was inadequate to clarify the genetic correlation between the 
tested strains. MDR-TB was approximately double time in 2008 compared with the value in 2007. Most of the new MDR-
TB was correlated with resident dense population regions.  
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INTRODUCTION 
 
Tuberculosis is a major cause of morbidity and mortality in 
the  world  from  a  single  infectious  agent  (Murray  et  al., 
1992). It was estimated that mycobacteria have infected 
one third of the global population with approximately 8.8 
million new cases in the year 2005 (WHO, 2007). Despite 
of tuberculosis is a global epidemic, it affects mainly the 
undeveloped  and  poor  countries  with  dense  population 
and few hygiene care where 98% of all TB deaths occur 
(Grange and Zumla, 2002).  
 Tuberculosis began to be treated with antibiotics in 
1940,  since  streptomycin  (STR)  and  para-aminosalicylic 
acid  (PAS)  were  discovered  and  then  used  for  TB 
treatment separately, but by the late 1940’s, combination 
treatment of both STR and PAS were used to overcome 
the developing resistance problem (Iseman, 2002). Now, 
several antibiotics are used for TB treatment to overcome 
the resistance problem. Isoniazid (INH), Ethambutol (E), 
and Rifampicin (RIF) were implemented in TB treatment 
(Murray,  2004),  then  pyrazinamide  (PZA)  was 
reintroduced during the 1980’s and came to replace STR 
in the regiment in several places (Iseman, 2002). Since 
that time, no new TB drug has been discovered (Saltini, 
2006).  
The increase in antibiotic resistance has generated 
considerable medical problems in TB treatment, since the 
increased death rate is attributed to the emergence of new 
resistant strains of M. tuberculosis. Multidrug-resistant TB 
(MDR-TB),  associated  with  high  death  rates  of  50%  to 
80%,  in  a  relatively  short  time  (4  to  16  weeks)  from 
diagnosis (Dooley et al., 1992).  
MDR-TB are the strains that are resistant to at least 
two of the best anti-TB drugs, Isoniazid and Rifampin. The 
treatment  success  rate  for  strains  resistant  to  both  RIF 
and INH varied between 44-77%, compared with > 90% 
for fully susceptible strains (Loddenkemper et al., 2002). 
The  WHO  and  the  International  Union  Against 
Tuberculosis and Lung Diseases (IUATLD) publish yearly 
reports  which  estimate  and  analyze  the  prevalence  of 
drug  resistance  trends  (WHO  2003;  WHO  2008).  The 
most  important  conclusion  obtained  was  to  identify  TB 
drug resistant hot spot regions where specific efforts from 
the global society should be focused.   
The  tragedy  of  tuberculosis  treatment  is  that,  50 
years  after  the  introduction  of  effective  speciﬁc 
chemotherapy,  the  number  of  cases  and  the  more 
threatening is higher worldwide. There are an increasing 
number of infections with organisms which are resistant to 
the major anti-tuberculosis agents (Pablos-Mendez et al., 
1998; Dye, 2000; Dye and Espinal, 2000).  
The  epidemiology  of  TB  can  be  monitored  by 
screening the different genotypes present in the different 
areas.  Molecular  markers  reveal  differences  of  natural 
sites at the DNA level. These variations might be a single 
nucleotide  difference  in  a  gene  or  a  piece  of  repetitive 
DNA (Johns et al., 1997).  
The random ampliﬁed polymorphic DNA (RAPD) as a 
one  of  DNA  fingerprinting  technique  has  been  used  for 
differentiation  between  various  kinds  of  microorganisms 
(Williams  et  al.,  1990;  Bazzicalupo  and  Fani,  1996), 
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including  M.  tuberculosis  isolates  (Harn  et  al.,  1997; 
Richner  et  al.,  1997;  Rodriguez  et  al.,  2000;  Vázquez-
Marrufo  et  al.,  2008).  Moreover,  since  it  samples  the 
overall diversity of genomes and corresponds therefore to 
a generalist marker (Tibagrenc, 1995), this method allows 
the  comparison  of  genetic  diversity  between  different 
microorganisms.  
Molecular  typing  of  M.  tuberculosis  can  facilitate 
investigation into the transmission of TB. In the present 
study, we planned to investigate the prevalence of drug 
resistant mycobacteria at different locations in Egypt, and 
to  clarify  the  genetic  correlation  using  RAPD  analysis 
between the antibiotic resistant strains to get information 
about  transmission  of  MDR-TB  within  regions  with 
epidemic TB. 
The aim of our study is also to support the national 
and global efforts exerted in fighting tuberculosis diseases 
by  studying  of  the  percentages  of  multi  drug  resistant 
bacteria in two subsequent years in different governorates 
in  Egypt.  Also  the  genetic  correlations  between  the 
isolates were also examined.  
 
MATERIALS AND METHODS 
 
Bacterial strains 
 
We analyzed 72 strains of M. tuberculosis isolated from 
different  specimens  (newly  infected)  belonged  to  20 
governorates in  Egypt.  Mycobacteria  were  isolated  from 
pathological  samples  at  the  Tuberculosis  reference  lab, 
ministry of health central labs, Cairo, Egypt. The strains 
were  collected  and  grown  on  fresh  Loewenstein-Jensen 
slants at 37 ° C for 8 weeks. 
  The samples were collected in 2007 and 2008. Thirty 
five  strains  were  isolated in 2007 and  37  Mycobacterial 
strains  were  isolated  in  2008.  Of  these,  7  strains  were 
collected  from  patients  in  Cairo;  5  from  both  Giza  and 
Beny-Swief;  4  from  each  of Alexandria,  Suez,  Menofya, 
Sharkia,  Gharbia,  El-Menia;  3  strains  from  Dakahlia, 
Demiat,  Kafr  El-Sheekh,  Ismailia,  Assuit,  Sohag,  Quina, 
Aswan,  Red  Sea;  while 2 strains  from each of  Matrouh 
and Sewa, thus all regions in Egypt were covered (Figure 
1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Locations where the Mycobacteria were isolated  
Bacterial identification  
 
The bacteria were identified using routine bacteriological 
procedures (Baron and Finegold, 1990). Identification was 
then  confirmed  by  a  specific  gene  amplification  using 
Genekam  kits  for  Mycobacterium  tuberculosis 
identification  (Genekam  Biotechnology  AG,  Duisburg, 
Germany). 
 
RFLP analysis  
 
The  amplified  fragments  were  then  digested  with 
restriction  endonulease  Hae  III  enzyme  (Boehringer 
Mannheim)  from  Haemophilus  aegptius.  Hae  III 
recognizes  the  sequence  `5GG↓CC  3
`  and  generates 
blunt  end  fragments.  The  amount  of  enzyme  and  DNA, 
the buffer and ionic concentrations were calculated for a 
final volume of 50 μL reaction (Ausubel et al., 1995). 
 
Antibiotic susceptibility  
 
The antibiotic susceptibilities of all M. tuberculosis strains 
were tested (Fadda and Rose 1984) (data not shown). 
 
RAPD Fingerprinting  
 
Bacterial  DNA  was  prepared  from  fresh  culture  using 
Cetyltrimethylammonium  bromide  (Merck,  Darmstadt, 
Germany) (van Embden et al., 1993).  
  A total of 20 primers (Table 1) were initially screened 
for the ability to produce discriminatory polymorphism and 
reproducible  results.  As  slight  variations  in  banding 
patterns were noted even when the same DNA controls 
were  analyzed  simultaneously,  isolates  were  routinely 
assayed in duplicates. 
 
Table 1: Primers (10-mers) used in the pilot study to type 
six M. tuberculosis strains represents the antibiotics 
resistant groups.                         
 
Plasmid screening                                                                                                                            
 
Plasmids were extracted from bacterial colonies using two 
methods, (Brinbiom and Doly, 1979) and using mini-prep 
QIAGEN kits for plasmid extraction. 
 
 
 
Primer  Sequence  GC content 
OPA-02  TGCCGAGCTG  70 % 
OPA-03  AGTGAGCCAC  60% 
OPA-04  AATCGGGCTG  60% 
OPA-06  GGTCCCTGAC  70% 
OPA-08  GTGACGTAGG  60% 
OPA-13  CAGCACCCAC  70% 
OPA-15  TTCCGAACCC  60% Mal. J. Microbiol. Vol 7(3) 2011, pp. 139-145 
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RESULTS  
 
Identification of strains  
 
The results of routine bacteriological methods for bacterial 
identification  indicated  their  affiliation  to  Mycobacterium 
tuberculosis.  These  results  were  confirmed  on  the 
molecular level, since our strains and the positive control 
(Mycobacterium tuberculosis) showed a band of 317 bp 
according to Genekam TB kits protocol (Figure 2). 
 
RFLP analysis of PCR products 
 
Two visible fragments were observed after digestion of the 
amplified fragment with restriction endonuclease Hae III in 
each strain (Figure 3).  
 
 
Figure 2: Amplification of Tb specific fragment (317 bp) 
according to genekam kits. M: 100 bp DNA ladder, lanes 
labeled 2 – 67: Representative of our strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3:  Representative  RFLP  profile  of  amplified 
specific  317  bp  fragment.  Lanes  labeled  2  –  67: 
Representative of our strains. M: 100 bp DNA ladder. ND: 
not digested amplified fragment. 
 
Antibiotic susceptibility  
As shown in Figure 4, multidrug resistant strains represent 
about  19.4%  of  tested  strains  while  sensitive  strains 
represent  26.4  %  of  the  strains  tested.  The  multi-drug 
resistant  strains  were  analyzed  as  shown  in  Figure  5. 
Most  of  these  strains  were  resistant  to  INH,  Rif  and  St 
(64.3% of total MDR-TB strains). The results showed also 
that, 21.4% of MDR strains were resistant to INH, Rif, St, 
while these resistant to each of (INH, Rif, St, E) and (INH, 
Rif) were only 7.1% of each group.  
  Of  the  14  MDR-TB  strains,  4  strains  (28.5%)  were 
isolated in 2007, while 10 (71.4%), and were isolated in 
2008 (Figure 6). Most of the MDR-TB strains isolated in 
2008 where from densely populated regions (ranged from 
184 – 1602 residents/Km
2.) 
  Since  seventy  two  isolates  may  be  considered 
inadequate for analysis, Chi square test (χ2) was applied 
to  ensure  the  benignity  of  experimentation  and 
hypotheses.  The  results  of  this  analysis  relied  in  the 
acceptance region in the (χ2) reference table.  
 
Figure  4:  The  susceptibility  of  Mycobacterium 
tuberculosis strains towards used antibiotics. 
 
Fig. 5: Multi-drug resistant groups. 
Fig. 6: MDR-TB strains during studying period. 
 
RAPD-PCR 
To  show  the  reproducibility  of  the  RAPD-PCR  method, 
three  different  experiments  were  performed  using  8 
different  primers,  each  of  which  was  carried  out  on  3 Mal. J. Microbiol. Vol 7(3) 2011, pp. 139-145 
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different days (Figures 7 A – H). By comparing the anding 
patterns  visually,  slight  differences  between  the  strains 
could  be  recorded.  Applying  the  bands  distribution  to 
statistical programs (SPSS) had generated a dendrogram 
(Figure  8)  constructed  on  the  basis  of  the  different 
patterns  for  the  6  M.  tuberculosis  which  represent  the 
different antibiotic susceptibility groups. The dendrogram 
shows the genetic relationships among the different  
 
representative  strains.  The  strains  separated  into  two 
main  clusters,  at  about  76  %  similarity,  the  first  one 
contains the strains sensitive to E and INH (G1), whereas 
the  other  group  (G2) contains  the strains  resistant  to  E 
and  INH  (G2B).  The  sensitive  strain  separated  as  a 
distinct sub-cluster in the second group (G2A).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Fingerprint patterns of RAPD analysis performed with M. tuberculosis strains. Lanes: 1 (strain no. 2); 2 (strain 
no. 8); 3 (strain no. 16); 4 (strain no. 35); 5 (strain no. 40); 6 (strain no. 67); M (DNA molecular weight marker 100 bp 
ladder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Dendrogram constructed on the basis of the patterns and the genetic relationships of six representative strains 
obtained with the RAPD primers. Mal. J. Microbiol. Vol 7(3) 2011, pp. 139-145 
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Plasmid screening 
 
No plasmids were detected in any of the tested strains by 
using the described methods.  
 
DISCUSSION  
 
Tuberculosis  is  a  common  and  often  deadly  infectious 
disease caused by mycobacteria. The recent appearance 
of  multi drug-resistance  (MDR-TB)  has  necessitated the 
combination of two or more drugs be used to help delay 
the emergence of resistant strains. The delayed initiation 
of effective therapy is one of the major factors contributing 
to MDR-TB outbreaks. (Edlin et al., 1992; Pearson et al., 
1992).  
  Several  studies  and  reports  discussed  the 
Mycobacterium  tuberculosis  resistance  and  outbreak, 
when accompanied with the Immuno deficiency diseases 
(HIV).  Tuberculosis  is  particularly  insidious  problem  to 
those  who  have  AIDS.  In  these  patients  the  T-
lymphocytes  that  normally  mount  a  response  to  M. 
tuberculosis  are  being  destroyed  by  virus  and  patients 
cannot  response  to  therapy.  Usually  the  naturally  rates 
between  these  patients  raises  to  70  –  90%  within  4 
months  from  developing  the  symptoms  (WHO,  2008). 
Malcolm  (2000)  reported  that,  the  incidence  of  TB  is 
increasing markedly, since TB infections increased from 
91 cases (2.1 per 100,000 populations) in 1988 to a peak 
of 165 cases (3.7 per 100,000) in 1992. Similarly, Bloom 
and  Murray  (1992),  reported  that  the  occurrence  of  TB 
recorded extra 20% between 1985 and 1992 according to 
the Centers of diseases control and prevention, 1993. In 
1995,  Sepkowitz  et  al.  calculated  that  the  antibiotic 
resistant  rate  of  TB  was  as  high  as  36  %  from  the 
previous years in Minnesota, USA.   
  Christopher et al. (2002) have studied the Worldwide 
Incidence  of  Multidrug-Resistant  tuberculosis.  They 
surveyed  64  countries  for  the  MDR-TB,  and  they  found 
that the incidence of these MDR-TB strains has increased 
by 3.4%.  The highest rates were in Estonia (14%), Henan 
Province,  China  (11%),  and  Latvia  (9%).  Rifampin 
resistance for example has been shown to be associated 
with  genetic  alterations  in  an  81-bp  region  of  the  rpoB 
gene encoding  the  DNA-dependent  RNA  polymerase  b-
subunit (Musser, 1995).  
  Our results (Figure 4), showed that 19.5% of the 72 
tested strains were resistant to each INH and Rif (MDR-
TB),  whereas  26.4%  of  these  strains  were  susceptible. 
This  indicated  that  these  MDR-TB  strains  are  initially 
resistant  strains  and  are  usually  transmitted  through 
droplet which enters the respiratory tract of people usually 
living in urban get toes with generally poor quality of life. 
This contributes to the establishment of the disease and 
increase the concentration in the air. More than 25% of 
the  strains  still  susceptible.  71.4%  of  these  MDR-TB 
strains were isolated in 2008 while 28.5% isolated in 2007 
(Figure  6).  These  results  indicate  that  MDR-TB  strains 
increased during period of study (2007, 2008). Chi square 
test (χ2) was applied to ensure this hypothesis according 
to our available 72 samples. The results of this analysis 
lied in the acceptance region in the (χ2) reference table 
and this hypothesis (raise of MDR-TB) is accepted which 
is consistent with the global observations of increasing the 
MDR-TB strains.  
  Our results (Figure 5) showed that most of the MDR-
TB (64.3% of MDR-Strains and 6.5% of total strains tested) 
was resistant to Ethambutol in addition to INH + RIF. This 
proportion, however was 0% and 0.9% in the newly and 
retreated patients according to last survey of tuberculosis 
drug resistance done in Egypt during 2002 whereas a total 
number  of  849  patient  enrolled  632  new  and  217  old 
patients  (Programmatic  Management  of  Drug  Resistant-
TB, 2007). In this report also, the resistance to four first 
line antibiotics (INH, RIF, E, STR) was 1.4% and 25% in 
new and retreated patients respectively, while in our study 
is  7.1%  among  new  patients,  which  supports  again  the 
global  conclusions  of  increasing  the  MDR-TB  strains. 
Despite the use of the directly observed treatment short-
course strategy for controlling the disease since 1991, the 
incidence  is  still  increasing  in  some  countries,  e.g 
Morocco (Ottmani et al., 1998). 
  Despite the efforts exerted in fighting TB in Egypt and 
all over the world, the outbreak of this infectious disease 
still continued. That is may be due to that the efforts are 
made only  in  one  direction, the  clinical  and  health care 
angle. Since the socioeconomic and demographic factors 
play  a  major  role  in  the  spread  of  disease,  several 
precautious  should  be  taken  in  consideration.  HIV 
epidemic  as  well  as  these  demographic  and 
socioeconomic  factors  such  as  poor  quality  of  life  also 
serve  to  maintain  substantial  reservoir  for  potential 
infections (Bloom and Murray, 1992).  
  Sepkowitz et al.,
 (1995), have supported this opinion; 
they reported that more than twice the number of cases in 
1988, and a 25% increase from 1998, in the number of TB 
cases. However national reports indicated that infectious 
have  declined  steadily  since  1993.  These  authors 
analyzed these data to explain such unusual situation and 
they found that the most notable trend in the epidemiology 
of TB in Minnesota is the large and increasing number of 
cases among foreign-born persons. From 1995 to 1999, 
the  number  of  foreign-born  TB  cases  in  Minnesota 
doubled  while  the  number  of  cases  among  U.S.-born 
persons decreased about 42%. 
  WHO (2007), reported that, data from countries of the 
Eastern Mediterranean showed that MDR-TB among new 
cases  was  higher  than  previously  estimated  with  the 
exception of Morocco and Lebanon which showed 0.5% 
and  1.1%,  respectively.  However,  MDR-TB  among  new 
cases  were  5.4%,  and  2.9%  in  Jordan  and  Yemen, 
respectively.  The  Americas,  Central  Europe  and  Africa, 
reported  the  lowest  proportions  of  MDR-TB;  with  the 
notable exceptions of Peru, Rwanda, and Guatemala, with 
5.3%,  3.9%,  and  3.0%  MDR-TB  among  new  cases, 
respectively. 
  Not only the MDR-TB is rising with time throughout 
the  world,  but,  a  new  definition  in  October  2006  was 
announced,  namely  extensively  drug  resistant 
tuberculosis  (XDR-TB)  which  is  relatively  a  rare  type  of 
MDR-TB. XDR-TB is defined as TB which is resistant to Mal. J. Microbiol. Vol 7(3) 2011, pp. 139-145 
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isoniazid  and  rifampin,  and  also  resistant  to  any 
fluoroquinolone  and  at  least  one  of  three  injectable 
second-line  drugs  (i.e.,  amikacin,  kanamycin,  or 
capreomycin). XDR-TB is of special concern for persons 
with HIV infection or other conditions that can weaken the 
immune system. These persons are more likely to develop 
TB disease once they are infected with a higher mortality 
rate once they develop TB.  
  Several researchers have used RAPD fingerprinting 
for  genotyping  of  Mycobacterium  strains  besides  these 
specific  markers  for  M.  tuberculosis  typing.  Tazi  et  al., 
(2004), reported that, the values obtained with the RAPD 
data were almost always higher than those obtained with 
the MIRU data, which suggests that the RAPD technique 
allows detection of more mutational events than the MIRU 
technique.  However,  for  both  genetic  markers,  the 
diversity  was  notable  and  almost  equivalent  in  all  the 
subgroups  they  investigated.  The  polymorphism  rate 
showed  that  all  the  RAPD  primers  gave  polymorphic 
patterns in all  the  groups,  and  for the  MIRU VNTR loci 
only  1  out  of  the  12  loci  (locus  24)  was  totally 
monomorphic. The phylogenetic analysis showed that the 
Moroccan  M.  tuberculosis  isolates  were  not  separated 
from the other M. tuberculosis stocks, regardless of the 
analysis used (Wagner or neighbor-joining analysis based 
on MIRU or RAPD data). In 1995, Abed et al. used RAPD 
analysis but not on the whole genomic DNA but on16S-
23S  spacer  region.  They  demonstrated  that  the 
discriminatory  power  of  16S-23S  spacer  region-based 
RAPD  analysis  was  higher  than  when  whole  genomic 
DNA was used as a RAPD template. According to results 
of our RAPD analysis, we suggest that all strains belong 
to  very  close  genotypes,  since  the  similarity  coefficient 
was  more  than  75  %  according  to  the  primers  used.  It 
would be much helpful if another techniques in use. To 
discriminate  the  genetic  relation  and  the  epidemiology 
status, this will be done in further studies. Our results of 
plasmid(s) screening agree with the results concluded by 
other investigators, since no reports are available about 
extracting plasmid from Mycobacterium tuberculosis, but 
from other Mycobacterium species. Jucker and Falkinham, 
(1990), demonstrated that most of plasmids are found in 
environmental  mycobacterial  species,  such  as 
Mycobacterium fortuitum and Mycobacterium avium. They 
reported  that  approximately  50%  of  M.  avium  strains 
harbour plasmids and same spp. with multiple plasmids as 
demonstrated  by  Kibry  et  al.  (2002).  However,  thus  far 
there  is  no  evidence  the  species  belonging  to 
Mycobacterium  tuberculosis  have  natural  plasmids 
(Zainuddin and Dale, 1990).  
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